/Investor DB

Winton Ventures — Full Portfolio

6 tracked investments · listed companies and verified rows first

AmberBox Gunshot Detectionamberbox.comin𝕏Seed

AmberBox makes an indoor gunshot detection and response system that uses a patented tri-factor authentication method (percussion, audio, and infrared) to identify firearm discharges and automatically alert first responders.

CybersecurityDeep TechEnterprise SoftwareGovTechHardwareIoTSaaSSan Francisco, US

James Popper(CEO)

Co-investorsHCVCY CombinatorUncork Capital

Exonarexonar.comin𝕏

Exonar helps organizations discover and understand the data they hold at scale, enabling them to better protect and manage information assets.

CybersecurityData & InfrastructureEnterprise SoftwareLondon, GB

Danny Reeves(CEO)inSimon Orr(Chief Technology Officer)in

Co-investorsBeringeaAmadeus Capital Partners

Orthosonorthoson.comJan 2017

Unable to determine from the page provided.

BiotechHealthtechMedical DevicesTyler, US

Co-investorsAnjostBig Pi VenturesPerivoli InnovationsOxford Technology Management

Panaseerpanaseer.comin𝕏Jun 2018 · $10M

Panaseer provides a continuous controls monitoring platform that gives IT and security teams unified visibility across their assets and security controls.

CybersecurityEnterprise SoftwareSaaS

Nik Whitfield(Founder)inJonathan Gill(CEO)inCharaka Goonatilake(Founder)Mike MacIntyre(Founder)

Co-investorsAlbionVCAllegisCyber CapitalCisco InvestmentsEvolution Equity PartnersForgePoint CapitalNational Grid Partners+3 more

Tessiantessian.com𝕏Jun 2018 · $13M

Tessian provides AI-powered email security solutions that detect and prevent email-based cyberattacks and data loss for enterprises.

AI & Machine LearningCybersecurityEnterprise Software

Tim Sadler(Founder)inEdward Bishop(Founder)inEd Bishop(Founder)Thomas Adams(Founder)Tom Adams(Founder)

Co-investorsAccelBalderton CapitalCrane Venture PartnersForgePoint CapitalLocalGlobeMarch Capital Partners+9 more

Valink Therapeuticsvalinktx.cominSeries A

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)inIrsyad Khairil(Founder)in

Co-investorsHoxton VenturesLongeVCMetaplanetMK Venture CapitalOxonian VenturesP53 Invest+10 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.